When assessing tumor-resident Th17 and Th22 in the 4T1-IL6-KO, Th17 was expanded, whereas Th22 was significantly reduced, consistent with other reports that IL-6 is a key cytokine determinate of both type 3 lineages [33]. This evidence concerns the gene IL6 and neoplasm.